| RS2146126679 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146126872 |
SLC19A1;COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2146126966 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS2146127288 |
ACO2
|
Health Risk |
Likely pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS2146127377 |
ACO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated macular dystrophy, Infantile cerebellar-retinal degeneration |
| RS2146127577 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS2146127594 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS2146127824 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146127847 |
HNF4A
|
Health Risk |
Pathogenic |
Hyperinsulinism due to HNF1A deficiency, Hyperinsulinism due to HNF1A deficiency |
| RS2146127849 |
SAMHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 5, Chilblain lupus 2 |
| RS2146127862 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2146128464 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146128577 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146128620 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS2146130891 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS2146130979 |
SCARF2
|
Health Risk |
Pathogenic |
Van den Ende-Gupta syndrome, Van den Ende-Gupta syndrome |
| RS2146130989 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146131000 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146131503 |
SCARF2
|
Health Risk |
Pathogenic |
Van den Ende-Gupta syndrome, Van den Ende-Gupta syndrome |
| RS2146131738 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146131822 |
TCF3
|
Health Risk |
Pathogenic |
Agammaglobulinemia 8b, autosomal recessive |
| RS2146133110 |
SCARF2
|
Health Risk |
Pathogenic |
Van den Ende-Gupta syndrome, Van den Ende-Gupta syndrome |
| RS2146136449 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146137671 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146138978 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS2146138982 |
RTTN
|
Health Risk |
Likely pathogenic |
Microcephalic primordial dwarfism due to RTTN deficiency, Microcephalic primordial dwarfism due to RTTN deficiency |
| RS2146139034 |
ACO2
|
Health Risk |
Pathogenic |
Optic atrophy 9, Optic atrophy 9 |
| RS2146139087 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146139092 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146140052 |
ACO2;LOC130067544
|
Health Risk |
Likely pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS2146141304 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2146141332 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2146141455 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2146144018 |
SLC25A1
|
Health Risk |
Likely pathogenic |
— |
| RS2146144310 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2146144344 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146144384 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146144769 |
TCF4
|
Health Risk |
Likely pathogenic |
— |
| RS2146146010 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146146055 |
TCF3
|
Health Risk |
Likely pathogenic |
— |
| RS2146146556 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2146146624 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146147030 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146147510 |
CHEK2
|
Health Risk |
Likely pathogenic |
— |
| RS2146147977 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2146148231 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146148271 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2146149228 |
RTEL1
|
Health Risk |
Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2146149676 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2146150691 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2146151890 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Breast and/or ovarian cancer |
| RS2146152456 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146152668 |
CHEK2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2146153089 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146153237 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146153708 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2146153920 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2146153953 |
RTEL1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2146154211 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146154644 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146155398 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146155758 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146155911 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146156469 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2146156838 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146157133 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2146157952 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2146160463 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146160649 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS2146178007 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146178281 |
GINS1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to GINS1 deficiency, Combined immunodeficiency due to GINS1 deficiency |
| RS2146178462 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2146178601 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2146178784 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism type I A, Inborn genetic diseases |
| RS2146178875 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2146178942 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146179050 |
GNAS
|
Health Risk |
Likely pathogenic |
GNAS-related disorder, Uterine corpus endometrial carcinoma |
| RS2146182069 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2146182293 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2146182909 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146183586 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2146184314 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146184726 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type 1C |
| RS2146185615 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146185827 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146187014 |
MYO18B
|
Health Risk |
Likely pathogenic |
— |
| RS2146189762 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146192021 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146193795 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146197831 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2146200643 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2146204977 |
TLK2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2146208184 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2146208325 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146208770 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism type I A, GNAS-related disorder |
| RS2146209197 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146209517 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146209821 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2146210053 |
GNAS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2146210724 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |